Sinemet Related Clinical Trials
A Single Center, Randomized, Double-Blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopaâ„¢ With Sinemet® in Subjects With Stable Parkinson's Disease [Completed]
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects [Completed]
Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study [Recruiting]
Comparison of IPX054, Immediate-Release Carbidopa-Levodopa, and Controlled-Release Carbidopa-Levodopa in Subjects With Parkinson's Disease [Recruiting]
A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease [Completed]
High and Low Dose Treatment of Carbidopa in Parkinson's Disease [Recruiting]
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease [Recruiting]
Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients [Recruiting]
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. [Terminated]
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Recruiting]
Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease [Recruiting]
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's [Active, not recruiting]
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-Motor Symptoms in Patients With Idiopathic Parkinson's Disease [Recruiting]
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets [Recruiting]
Timing of Levodopa Treatment in Parkinson's Disease [Completed]
Neurobiological Principles Applied to the Rehabilitation of Stroke Patients [Recruiting]
The Effect of Dopamine on Motor Skills Training [Completed]
Talampanel to Treat Parkinson's Disease [Completed]
KW-6002 to Treat Parkinson's Disease [Completed]
Riluzole to Treat Parkinson's Disease [Completed]
ACP-103 to Treat Parkinson's Disease [Completed]
EMD 128130 for the Treatment of Parkinson's Disease [Completed]
Levetiracetam Treatment of L-Dopa Induced Dyskinesias [Completed]
Effects of Talampanel on Patients With Advanced Parkinson's Disease [Completed]
Lisuride Patch to Treat Parkinson's Disease [Completed]
JP-1730 to Treat Parkinson's Disease [Completed]
Substance Abuse Pre-Treatment Screening Study [Recruiting]
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence [Recruiting]
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-Dose Wearing Off [Recruiting]
12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa [Completed]
Transcranial Electrical Polarization to Treat Symptoms of Parkinson's Disease [Recruiting]
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease [Completed]
Study of LY300164 for the Treatment of Parkinson's Disease [Completed]
Relationship of Dopamine to Cognitive Function in Parkinson's Disease [Completed]
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease [Completed]
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa [Completed]
An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients [Completed]
Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGGâ„¢ Injection [Completed]
Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGGâ„¢ Injection [Completed]
The Effect of Beta-Glucan in Non-Small Cell Lung Cancer [Recruiting]
Medications for Stopping Cocaine Dependence and Preventing Relapse [Recruiting]
Prevention of Acute Voiding Difficulty After Radical Proctectomy [Recruiting]
|
